COM:ALAUNOS
Alaunos Therapeutics
- Stock
Last Close
2.32
22/11 21:00
Market Cap
9.61M
Beta: -
Volume Today
7.88K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 6.97M - | 6.97M 0% | ||||||||||
average payables | 965.50K - | 1.21M 25.63% | 2.01M 65.38% | 1.08M 46.06% | 2.29M 111.32% | 2.56M 12.05% | 806.50K 68.52% | 933K 15.69% | 1.16M 24.76% | 1.38M 18.43% | 1.00M 27.28% | |
average receivables | 101.50K - | 145K 42.86% | 295.50K 103.79% | 233.50K 20.98% | 20K 91.43% | 941.50K 4,607.50% | 2.60M 175.84% | 4.00M 53.93% | 2.89M 27.75% | 557.50K 80.70% | 2.50K 99.55% | |
book value per share | 0.57 - | 0.33 41.76% | 0.70 108.19% | -0.59 185.10% | -0.71 19.25% | 0.60 184.34% | 0.57 5.12% | 0.59 4.55% | 0.27 54.21% | 0.18 34.43% | 0.00 99.78% | |
capex per share | -0.00 - | -0.00 24.25% | -0.00 72.14% | -0.00 28.63% | -0.01 27.36% | -0.00 40.57% | -0.00 47.13% | -0.05 2,658.36% | -0.02 66.77% | -0.00 93.58% | -0.00 98.76% | |
capex to depreciation | -0.18 - | -0.42 133.56% | -1.15 176.26% | -1.90 64.64% | -2.00 5.12% | -0.80 60.03% | -0.45 43.44% | -8.67 1,819.88% | -1.28 85.24% | -0.08 93.88% | -0.09 8.70% | |
capex to operating cash flow | 0.00 - | 0.01 137.41% | 41.20 782,273.06% | 0.01 99.98% | 0.01 42.70% | 0.01 31.16% | 0.01 25.10% | 0.17 2,367.13% | 0.05 68.48% | 0.01 86.33% | 0.01 11.55% | |
capex to revenue | -0.17 - | -0.14 14.81% | -0.10 32.34% | -0.08 15.56% | -0.12 43.64% | -3.14 2,625.37% | -8.35 - | -0.07 99.11% | -39.40 53,199.44% | |||
cash per share | 0.79 - | 0.42 46.67% | 1.12 165.10% | 0.62 44.60% | 0.52 16.65% | 0.43 16.98% | 0.47 10.38% | 0.55 15.61% | 0.35 35.37% | 0.18 49.29% | 0.00 99.79% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 674.76 - | 46.81 - | ||||||||||
days sales outstanding | 66.16 - | 38.55 41.73% | 37.58 2.51% | 1.12 97.03% | 1.09 2.84% | 4.66K 429,211.32% | 1.02K - | 0.50 99.95% | 73 14,510.00% | |||
debt to assets | 0.02 - | 0.03 52.61% | 0.31 841.01% | 0.30 2.93% | ||||||||
debt to equity | 0.02 - | 0.04 56.85% | 0.51 1,202.65% | 0.51 0.05% | ||||||||
dividend yield | 0.01 - | 0.06 - | ||||||||||
earnings yield | -0.15 - | -0.06 59.52% | -0.12 85.90% | -0.24 105.64% | -0.10 59.56% | -0.20 106.56% | -0.22 13.39% | -0.15 33.50% | -0.33 120.45% | -0.27 19.04% | -0.00 99.22% | |
enterprise value | 304.79M - | 469.93M 54.18% | 901.49M 91.84% | 616.54M 31.61% | 495.98M 19.55% | 206.63M 58.34% | 715.34M 246.19% | 418.03M 41.56% | 187.01M 55.26% | 121.59M 34.98% | 16.95B 13,839.72% | |
enterprise value over ebitda | -5.24 - | -8.51 62.38% | -7.51 11.79% | -3.73 50.27% | -9.50 154.57% | -3.82 59.78% | 247.27 6,569.60% | -5.20 102.10% | -2.46 52.74% | -3.50 42.50% | -494.62 14,019.52% | |
ev to operating cash flow | -5.12 - | -12.82 150.35% | -90.15K 702,976.07% | -10.57 99.99% | -9.07 14.17% | -4.18 53.95% | -17.51 319.09% | -7.33 58.13% | -3.04 58.51% | -4.16 36.72% | -562.30 13,418.87% | |
ev to sales | 380.99 - | 342.26 10.16% | 208.10 39.20% | 89.86 56.82% | 77.63 13.61% | 1.42K 1,723.12% | 469.86 - | 41.61 91.14% | 3.39M 8,146,270.03% | |||
free cash flow per share | -0.69 - | -0.36 47.50% | -0.00 99.08% | -0.45 13,319.30% | -0.40 10.39% | -0.35 14.03% | -0.24 29.58% | -0.32 30.07% | -0.30 5.15% | -0.14 55.12% | -0.00 98.60% | |
free cash flow yield | -0.16 - | -0.07 55.06% | -0.00 99.44% | -0.08 20,743.81% | -0.10 15.80% | -0.19 90.32% | -0.05 72.10% | -0.13 143.63% | -0.28 119.29% | -0.21 24.74% | -0.00 99.14% | |
graham net net | 0.53 - | 0.31 41.70% | 0.60 91.12% | -0.79 232.08% | -0.96 22.02% | 0.37 138.94% | -0.16 142.81% | 0.46 386.79% | 0.19 59.27% | 0.09 51.59% | 0.00 99.72% | |
graham number | 2.93 - | 1.54 47.52% | 3.87 151.86% | 4.11 6.14% | 2.51 38.91% | 2.23 11.29% | 3.67 64.79% | 2.24 39.07% | 1.48 33.92% | 0.83 43.73% | 0.00 99.47% | |
income quality | 1.04 - | 1.15 10.67% | 0.00 99.99% | 0.35 423,630.17% | 1.01 185.21% | 0.93 7.48% | 0.35 62.75% | 0.71 105.55% | 0.78 9.49% | 0.77 0.74% | 0.86 10.71% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 95.24 - | 3.71 96.10% | 10.01K 269,509.99% | 16.53K 65.17% | -64.45 100.39% | 68.32 206.01% | -65.61 - | -11.13 83.04% | 17.84 260.27% | |||
interest debt per share | -0.01 - | -0.12 1,543.27% | -0.00 99.92% | -0.00 19.85% | 0.01 8,003.19% | -0.01 190.71% | 0.01 354.71% | 0.02 63.98% | 0.14 520.45% | 0.10 26.74% | -0.00 100.12% | |
inventory turnover | ||||||||||||
invested capital | 0.02 - | 0.04 56.85% | 0.51 1,202.65% | 0.51 0.05% | ||||||||
market cap | 372.99M - | 512.73M 37.46% | 1.04B 103.27% | 697.59M 33.07% | 566.92M 18.73% | 268.36M 52.66% | 792.73M 195.40% | 528.28M 33.36% | 233.69M 55.76% | 141.13M 39.61% | 16.96B 11,913.38% | |
net current asset value | 47.93M - | 32.69M 31.79% | 86.17M 163.58% | -78.76M 191.41% | -111.63M 41.73% | 74.80M 167.01% | -3.62M 104.84% | 108.23M 3,088.02% | 42.02M 61.17% | 27.42M 34.76% | 6.30M 77.00% | |
net debt to ebitda | 1.17 - | 0.78 33.90% | 1.17 51.16% | 0.49 58.12% | 1.36 176.99% | 1.14 15.99% | -26.75 2,442.88% | 1.37 105.13% | 0.61 55.26% | 0.56 8.24% | 0.18 68.59% | |
net income per share | -0.66 - | -0.31 52.71% | -0.96 204.69% | -1.27 32.39% | -0.40 68.71% | -0.37 6.70% | -1.06 186.21% | -0.38 64.50% | -0.36 4.64% | -0.17 51.72% | -0.00 98.73% | |
operating cash flow per share | -0.69 - | -0.36 47.66% | -0.00 99.98% | -0.45 560,894.79% | -0.40 10.75% | -0.34 13.68% | -0.24 29.42% | -0.27 11.80% | -0.29 5.42% | -0.13 53.04% | -0.00 98.60% | |
payables turnover | 0.54 - | 7.80 - | ||||||||||
receivables turnover | 5.52 - | 9.47 71.63% | 9.71 2.58% | 326.71 3,263.68% | 336.26 2.92% | 0.08 99.98% | 0.36 - | 730.50 203,815.95% | 5 99.32% | |||
research and ddevelopement to revenue | 53.56 - | 23.82 55.53% | 24.65 3.48% | 23.00 6.70% | 7.06 69.32% | 233.79 3,213.18% | 124.73 - | 8.56 93.14% | 3.26K 37,926.41% | |||
return on tangible assets | -0.80 - | -0.70 11.73% | -0.78 11.19% | -1.55 98.97% | -0.51 66.91% | -0.56 8.64% | -1.63 191.78% | -0.54 66.96% | -0.81 50.44% | -0.58 28.57% | -4.25 634.52% | |
revenue per share | 0.01 - | 0.01 45.85% | 0.03 154.42% | 0.05 52.34% | 0.05 11.33% | 0.00 97.82% | 0.00 - | 0.01 624.94% | 0.00 100.00% | |||
roe | -1.16 - | -0.94 18.79% | -1.37 46.36% | 2.14 255.58% | 0.56 73.76% | -0.62 210.63% | -1.87 201.65% | -0.64 66.04% | -1.32 108.26% | -0.98 26.37% | -5.57 471.36% | |
roic | -1.13 - | -0.34 70.20% | -1.37 307.47% | 2.14 255.70% | 0.57 73.17% | -0.62 207.76% | 0.03 105.54% | -0.59 1,829.13% | -0.82 37.80% | -0.58 29.60% | -5.43 844.51% | |
sales general and administrative to revenue | 19.58 - | 8.86 54.74% | 4.07 54.03% | 2.10 48.56% | 2.32 10.53% | 136.42 5,790.10% | 69.26 - | 4.50 93.51% | 2.44K 54,235.59% | |||
shareholders equity per share | 0.57 - | 0.33 41.76% | 0.70 108.19% | -0.59 185.10% | -0.71 19.25% | 0.60 184.34% | 0.57 5.12% | 0.59 4.55% | 0.27 54.21% | 0.18 34.43% | 0.00 99.78% | |
stock based compensation to revenue | 4.38 - | 3.45 21.20% | 1.85 46.56% | 1.23 33.27% | 1.32 7.41% | 51.60 3,799.81% | 27.07 - | 1.21 95.54% | 560 46,280.95% | |||
tangible asset value | 49.38M - | 33.84M 31.47% | 87.37M 158.18% | -77.30M 188.47% | -96.81M 25.24% | 85.56M 188.39% | 123.98M - | 58.06M 53.17% | 38.55M 33.59% | 6.31M 83.64% | ||
tangible book value per share | 0.57 - | 0.33 41.76% | 0.70 108.19% | -0.59 185.10% | -0.71 19.25% | 0.60 184.34% | 0.59 - | 0.27 54.21% | 0.18 34.43% | 0.00 99.78% | ||
working capital | 62.51M - | 33.26M 46.79% | 134.40M 304.07% | 89.08M 33.72% | 69.93M 21.50% | 74.80M 6.97% | 92.97M 24.28% | 112.22M 20.71% | 62.79M 44.05% | 29.63M 52.81% | 6.30M 78.72% |
All numbers in USD (except ratios and percentages)